adenosine has been researched along with Hypertension, Pulmonary in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.45) | 18.7374 |
| 1990's | 26 (44.83) | 18.2507 |
| 2000's | 10 (17.24) | 29.6817 |
| 2010's | 15 (25.86) | 24.3611 |
| 2020's | 5 (8.62) | 2.80 |
| Authors | Studies |
|---|---|
| De Luca, D; Genet, L | 1 |
| Lee, NT; Nandurkar, HH; Sashindranath, M; Willcox, A | 1 |
| Chen, B; Huang, J; Jiang, Y; Liu, Y; Sun, Z; Xia, Y; Zhang, Y | 1 |
| Baber, SR; Cornett, EM; Kaye, AD; Kaye, RJ; Sharief, MT | 1 |
| Cheng, L; Eilbert, W | 1 |
| Gao, X; Wu, Y; Xu, Y; Zhan, S | 1 |
| Adatia, I; Atkins, DL; Checchia, PA; DeCaen, A; Fink, EL; Hazinski, MF; Hoffman, GM; Jefferies, JL; Kleinman, M; Krawczeski, CD; Laussen, PC; Licht, DJ; MacLaren, G; Macrae, D; Marino, BS; Ravishankar, C; Samson, RA; Tabbutt, S; Thiagarajan, RR; Toms, R; Tweddell, J | 1 |
| Bondesson, U; Egeröd, H; Hedeland, M; Henrohn, D; Sandqvist, A; Schneede, J; Wernroth, L; Wikström, G | 1 |
| Amione-Guerra, J; Blackburn, MR; Bruckner, BA; Bunge, RR; Chen, NY; Davies, J; Eltzschig, HK; Garcia-Morales, LJ; Karmouty-Quintana, H; Loebe, M; Luo, F; Melicoff, E; Pandit, LM; Philip, K; Volcik, KA; Weng, T | 1 |
| Anyanwu, AC; Burant, CF; Goonewardena, SN; Hyman, MC; Kanthi, Y; Petrovic-Djergovic, D; Pinsky, DJ; Rattan, R; Robichaud, P; Visovatti, SH; Wang, J | 1 |
| Baillie, TJ; Nicholls, SJ; Sanders, P; Sidharta, S; Steele, PM; Teo, K; Willoughby, S; Worthley, MI; Worthley, SG | 1 |
| Chen, XM; Fang, X; Huang, XL; Tan, JX; Tao, MJ | 1 |
| Han, ZY; Jiang, X; Jing, ZC; Lv, H; Ma, CR; Pu, JL; Wang, Y; Wu, Y; Xu, XQ; Yang, YJ | 1 |
| Jackson, EK; Rafikova, O; Tofovic, SP | 1 |
| Opitz, CF; Rubin, LJ | 1 |
| Amaral, CF; Oliveira, EC; Ribeiro, AL | 1 |
| Alnuaimat, H; Mubarak, K; Tonelli, AR | 1 |
| Chen, TB; Cheng, KA; Fang, Q; Gao, P; Jiang, XC; Li, MT; Liu, YT; Tian, Z; Wang, Q; Zeng, XF | 1 |
| Cui, CS; Han, XM; Meng, J; Sheng, XT; Wang, QG; Xue, HM; Zhang, DZ; Zhang, P; Zhu, XY | 1 |
| Bluemke, DA; Boyce, DM; Girgis, RE; Goldstein, TA; Hassoun, PM; Lechtzin, N; Lima, JA; Mathai, SC; Shehata, ML; Sibley, CT; Singh, S; Skrok, J; Vogel-Claussen, J; Zheng, J | 1 |
| Fu, LJ; Guo, Y; Huang, MR; Li, F; Zhao, PJ; Zhou, AQ | 1 |
| Jiang, X; Jing, ZC; Li, XL; Wang, H; Xie, WP; Zhang, R; Zong, F; Zuo, XR | 1 |
| Canpolat, U; Kaya, EB | 1 |
| Fang, X; Huang, DN; Huang, XL; Tan, JX; Wang, B | 1 |
| Amaro Cendón, A | 1 |
| Hua, Y; Liao, K; Liu, H; Tang, W; Zhou, T | 1 |
| Evans, TW; Hansell, DM; Jones, AT | 1 |
| Widmar, B | 1 |
| Parra R, C; Uriarte G de C, P; Wainstein G, E; Zagolin B, M | 1 |
| Nakashima, M | 1 |
| Bache, RJ; Gold, FL | 1 |
| Kaufmann, E; Long, W; Nootens, M; Rich, S; Schrader, B; Vestal, R | 1 |
| Pearl, RG | 1 |
| Albes, JM; Haverich, A; Rohde, R | 1 |
| Inbar, S; Kaufmann, E; Rich, S; Schrader, BJ; Vestal, RE | 1 |
| Nootens, M; Rich, S | 1 |
| Fullerton, DA; Grover, FL; Jones, SD; McIntyre, RC | 1 |
| Brett, SJ; Evans, TW; Gibbs, R; Pepper, JR; Simon, J | 1 |
| Brown, JM; Fullerton, DA; Jaggers, J; Jones, SD; McIntyre, RC | 1 |
| Kavanagh, BP; Pearl, RG; Thompson, JS | 1 |
| Crowley, MR | 1 |
| Cailes, J; du Bois, RM; Evans, TW; Winter, S | 1 |
| Buettner, P; Lee, J; Patole, S; Whitehall, J | 1 |
| Kavanagh, BP; Patterson, KW; Pearl, RG; Wall, MH | 1 |
| Deb, B; Kavanagh, BP; Patterson, KW; Pearl, RG | 1 |
| Al-Bekairi, AM; Al-Shabanah, OA; El-Kashef, H; Elmazar, MM | 1 |
| Cantó Pastor, M; Charco Mora, P; García Escobar, M | 1 |
| Aranda, M; Bradford, KK; Pearl, RG | 1 |
| Gaubert, ML; Guieu, RP; Levy, S; Paganelli, F; Saadjian, AY | 1 |
| Lee, J; Patole, S; Whitehall, J | 1 |
| Devaux, C; Guieu, RP; Juin, MA; Lévy, S; Paganelli, F; Saadjian, AY | 1 |
| Kesten, S; McLaughlin, V; Rich, S; Sharma, K; Stevens, D; Szidon, P | 1 |
| Deshmukh, DR; Konduri, GG; Mukhopadhyay, A; Woodard, LL | 1 |
| Inbar, S; Kaufmann, L; Rich, S; Schrader, BJ; Vestal, RE | 1 |
| Davilén, J; Owall, A; Sollevi, A | 1 |
| Barnes, PJ; Evans, TW; Griffiths, MJ; McCormack, DG; Morgan, CJ; Morgan, JM | 1 |
| Groves, BM; Reeves, JT; Weir, EK | 1 |
| Bradley, JD; Dahms, TE; Webster, RO; Zanaboni, PB | 1 |
7 review(s) available for adenosine and Hypertension, Pulmonary
| Article | Year |
|---|---|
CD39 in the development and progression of pulmonary arterial hypertension.
Topics: Adenosine; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Pulmonary Arterial Hypertension; Vascular Remodeling | 2022 |
N6-Methyladenosine Modifications in Pulmonary Hypertension.
Topics: Adenosine; Apoptosis; Humans; Hypertension, Pulmonary; RNA | 2023 |
RNA modifications in cardiovascular diseases, the potential therapeutic targets.
Topics: Adenosine; Animals; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Epigenesis, Genetic; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy; Metabolic Syndrome; Methylation; Mice; Microcirculation; Myocardium; Regeneration; Reperfusion Injury; RNA; RNA Processing, Post-Transcriptional; RNA, Untranslated; Transcriptome | 2021 |
Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.
Topics: Adenosine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Child; Guidelines as Topic; Heart Diseases; Heart Failure; Humans; Hypertension, Pulmonary; Vasodilator Agents | 2018 |
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
Topics: Adenosine; Calcium Channel Blockers; Drug Therapy, Combination; Epoprostenol; Evidence-Based Medicine; Humans; Hypertension, Pulmonary; Iloprost; Nitric Oxide; Vasodilation; Vasodilator Agents | 2010 |
[Hemodynamic study: indications for right- and left-sided catheterization in the diagnosis and follow-up of pulmonary hypertension].
Topics: Adenosine; Blood Pressure; Calcium Channel Blockers; Cardiac Catheterization; Epoprostenol; Hemodynamics; Humans; Hypertension, Pulmonary; Nitric Oxide; Oximetry; Pulmonary Artery; Vascular Resistance | 2011 |
When cure is care: diagnosis and management of pulmonary arterial hypertension.
Topics: Adenosine; Algorithms; Antihypertensive Agents; Bosentan; Bronchodilator Agents; Calcium Channel Blockers; Decision Trees; Diagnosis, Differential; Epoprostenol; Fatal Outcome; Fenfluramine; Health Promotion; Humans; Hypertension, Pulmonary; Iloprost; Lung Transplantation; Nitric Oxide; Nurse Practitioners; Primary Health Care; Prognosis; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sulfonamides; Vasodilator Agents | 2005 |
5 trial(s) available for adenosine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.
Topics: Adenosine; Adult; Aged; Blood Gas Analysis; Cardiac Catheterization; Drug Administration Routes; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Vardenafil Dihydrochloride; Vasodilator Agents | 2015 |
Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
Topics: Acute Disease; Adenosine; Administration, Inhalation; Adolescent; Adult; Child; Heart Defects, Congenital; Hemodynamics; Humans; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Severity of Illness Index; Young Adult | 2011 |
Adenosine effectively controls pulmonary hypertension after cardiac operations.
Topics: Adenosine; Aged; Cardiac Surgical Procedures; Hemodynamics; Humans; Hypertension, Pulmonary; Intraoperative Care; Intraoperative Complications; Middle Aged; Monitoring, Intraoperative; Vasodilator Agents; Ventricular Dysfunction, Right | 1996 |
Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension.
Topics: Adenosine; Cardiac Output; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Pulmonary Veins; Substance P; Vascular Resistance; Vasodilation | 1996 |
Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
Topics: Adenosine; Adult; Capillaries; Cardiac Output; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Male; Microcirculation; Middle Aged; Prospective Studies; Pulmonary Circulation; Scleroderma, Systemic; Stroke Volume; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents | 1998 |
46 other study(ies) available for adenosine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Adenosine reverses life-threatening persistent pulmonary hypertension of the neonate refractory to triple vasodilator therapy.
Topics: Adenosine; Administration, Inhalation; Humans; Hypertension, Pulmonary; Iloprost; Infant, Newborn; Nitric Oxide; Vasodilator Agents | 2022 |
Vasodepressor Effects of Adenosine in the Cat are Independent of Cyclooxygenase, Potassium Channels, and Nitric Oxide Pathways.
Topics: Adenosine; Animals; Calcium Channels, L-Type; Cats; Disease Models, Animal; Female; Hypertension, Pulmonary; Male; Nitric Oxide; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Receptor, Adenosine A1; Receptors, Adenosine A2; Signal Transduction; Vasodilator Agents | 2019 |
High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 2020 |
Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension.
Topics: Adenosine; Aged; Female; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Pulmonary Fibrosis; Vascular Remodeling | 2016 |
Purinergic dysregulation in pulmonary hypertension.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Antihypertensive Agents; Apyrase; Arterial Pressure; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Hydrolysis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Pulmonary Artery; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X1; Severity of Illness Index; Signal Transduction; Suramin; Vascular Remodeling; Ventricular Remodeling | 2016 |
The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study.
Topics: Adenosine; Adult; Aged; Arterial Pressure; Biomarkers; Cardiorespiratory Fitness; Disease Progression; Elastic Modulus; Female; Hemodynamics; Humans; Hyperemia; Hypertension, Pulmonary; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Pulmonary Artery; Stroke Volume; Time Factors; Vascular Resistance; Vascular Stiffness; Vasodilator Agents; Ventricular Function, Right; Walk Test | 2017 |
[Effects of continuous adenosine infusion on pulmonary hypertension in chronically hypoxic rats].
Topics: Adenosine; Animals; Chronic Disease; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Infusions, Subcutaneous; Male; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2008 |
Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension.
Topics: Adenosine; Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Calcium Channel Blockers; Cardiac Catheterization; Child; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Iloprost; Male; Middle Aged; Vasodilator Agents | 2009 |
Adenosine deaminase-adenosine pathway in hemolysis-associated pulmonary hypertension.
Topics: Adenosine; Adenosine Deaminase; Hemolysis; Humans; Hypertension, Pulmonary; Models, Biological; Signal Transduction | 2009 |
Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?
Topics: Adenosine; Administration, Inhalation; Diltiazem; Humans; Hypertension, Pulmonary; Iloprost; Nitric Oxide; Vasodilator Agents | 2009 |
Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide.
Topics: Adenosine; Administration, Inhalation; Adolescent; Adult; Aged; Cardiac Output; Child; Child, Preschool; Drug Synergism; Female; Humans; Hypertension, Pulmonary; Male; Maximum Tolerated Dose; Middle Aged; Nitric Oxide; Pulmonary Circulation; Treatment Outcome; Vasodilator Agents; Young Adult | 2010 |
[Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Topics: Adenosine; Adult; Antihypertensive Agents; Blood Pressure; Cardiac Catheterization; Connective Tissue Diseases; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Prospective Studies; Vasodilation; Vasodilator Agents; Young Adult | 2009 |
Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension.
Topics: Adenosine; Aged; Aged, 80 and over; Cardiac Catheterization; Case-Control Studies; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Image Interpretation, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Scleroderma, Systemic; Statistics, Nonparametric; Vasodilator Agents; Ventricular Dysfunction, Right | 2011 |
[Adenosine for pulmonary vasodilator testing in children with idiopathic pulmonary arterial hypertension].
Topics: Adenosine; Adolescent; Child; Child, Preschool; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Infant; Male; Pulmonary Artery; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents | 2011 |
Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers.
Topics: Adenosine; Adult; Calcium Channel Blockers; Cohort Studies; Familial Primary Pulmonary Hypertension; Female; Follow-Up Studies; Heart Function Tests; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Mass Screening; Retrospective Studies; Treatment Outcome; Vasodilator Agents; Young Adult | 2012 |
[How to do vasoreactivity test?].
Topics: Adenosine; Administration, Inhalation; Antihypertensive Agents; Bronchodilator Agents; Catheterization, Swan-Ganz; Epoprostenol; Hemodynamics; Humans; Hypertension, Pulmonary; Iloprost; Nitric Oxide; Pulmonary Artery; Vasodilator Agents | 2012 |
[Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Topics: Adenosine; Angiotensin II; Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Purinergic P1 Receptor Agonists; Random Allocation; Rats; Rats, Sprague-Dawley; Renin | 2012 |
[Dose-related response of adenosine in hypoxic pulmonary hypertension in canines].
Topics: Adenosine; Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Vasodilator Agents | 1999 |
Quantifying pulmonary perfusion in primary pulmonary hypertension using electron-beam computed tomography.
Topics: Adenosine; Adult; Blood Flow Velocity; Contrast Media; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Image Processing, Computer-Assisted; Iohexol; Lung; Male; Mathematical Computing; Middle Aged; Pulmonary Artery; Reference Values; Regional Blood Flow; Tomography, X-Ray Computed; Vascular Resistance; Vasodilator Agents | 2004 |
[Clinical, functional and hemodynamic features of patients with pulmonary arterial hypertension].
Topics: Adenosine; Adolescent; Adult; Aged; Dyspnea; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prognosis; Prospective Studies; Pulmonary Wedge Pressure; Severity of Illness Index; Statistics, Nonparametric; Vasodilator Agents | 2006 |
[Functional changes in the pulmonary arteries of pulmonary hypertensive rats].
Topics: Adenosine; Animals; Histamine; Hypertension, Pulmonary; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Norepinephrine; Pulmonary Artery; Rats; Rats, Inbred Strains; Tyramine; Vasoconstrictor Agents | 1982 |
Transmural right ventricular blood flow during acute pulmonary artery hypertension in the sedated dog. Evidence for subendocardial ischemia despite residual vasodilator reserve.
Topics: Adenosine; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Endocardium; Heart Ventricles; Hypertension, Pulmonary; Hypnotics and Sedatives; Pulmonary Artery; Vasodilation | 1982 |
Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
Topics: Adenosine; Adult; Blood Pressure; Cardiac Output; Epoprostenol; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Circulation; Vascular Resistance | 1995 |
Adenosine produces pulmonary vasodilation in the perfused rabbit lung via an adenosine A2 receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Animals; Hypertension, Pulmonary; Lung; Male; Perfusion; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Rabbits; Receptors, Adrenergic, alpha-2; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
Protection of the right ventricular myocardium during acute right heart failure from pulmonary hypertension.
Topics: Acute Disease; Adenosine; Allopurinol; Animals; Cardioplegic Solutions; Disease Models, Animal; Embolectomy; Evaluation Studies as Topic; Extracorporeal Circulation; Glucose; Glutathione; Heart Arrest, Induced; Heart Failure; Hypertension, Pulmonary; Insulin; Male; Myocardial Reperfusion Injury; Organ Preservation Solutions; Pulmonary Embolism; Raffinose; Rats; Rats, Inbred Lew; Tromethamine; Ventricular Function, Right | 1994 |
Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
Topics: Adenosine; Adult; Calcium Channel Blockers; Catheterization, Swan-Ganz; Diltiazem; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Male; Nifedipine; Pulmonary Circulation; Stroke Volume; Thermodilution; Vascular Resistance | 1993 |
Successful management of labor and delivery in primary pulmonary hypertension.
Topics: Adenosine; Adult; Delivery, Obstetric; Female; Humans; Hypertension, Pulmonary; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care | 1993 |
Adenosine for refractory pulmonary hypertension.
Topics: Adenosine; Adult; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Middle Aged; Vasodilator Agents | 1996 |
Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Alprostadil; Animals; Drug Synergism; Enzyme Inhibitors; Hypertension, Pulmonary; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Nitroprusside; Perfusion; Pulmonary Circulation; Rabbits; Vasodilator Agents | 1996 |
Oxygen-induced pulmonary vasodilation is mediated by adenosine triphosphate in newborn lambs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adenosine Triphosphate; Animals; Animals, Newborn; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Hypertension, Pulmonary; Nitric Oxide; Nitroarginine; Oxygen; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Purinergic Antagonists; Sheep; Theophylline; Thromboxane A2; Triazines; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1997 |
Improved oxygenation following adenosine infusion in persistent pulmonary hypertension of the newborn.
Topics: Adenosine; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Male; Oxygen; Partial Pressure; Retreatment; Treatment Outcome | 1998 |
Inhibition of endogenous nitric oxide synthesis potentiates the effects of sodium nitroprusside but not of adenosine in experimental pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Synergism; Hemodynamics; Hypertension, Pulmonary; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rabbits; Vasodilator Agents | 1999 |
Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Administration, Inhalation; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Nitric Oxide; Nitroprusside; Rabbits; Vascular Resistance; Vasodilator Agents | 1999 |
Effect of adenosine on pulmonary circulation of rabbits.
Topics: Adenosine; Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Guanylate Cyclase; Hypertension, Pulmonary; In Vitro Techniques; Male; Pulmonary Artery; Pulmonary Circulation; Purinergic P1 Receptor Antagonists; Rabbits; Serotonin; Vasodilator Agents | 1999 |
[Effectiveness of adenosine as a pulmonary vasodilator during weaning from extracorporeal circulation after mitral valve replacement in a patient with severe pulmonary hypertension].
Topics: Adenosine; Aged; Catheters, Indwelling; Extracorporeal Circulation; Female; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Hypertension, Pulmonary; Inactivation, Metabolic; Intraoperative Complications; Mitral Valve Stenosis; Postoperative Care; Tricuspid Valve Insufficiency; Vasodilator Agents; Ventricular Dysfunction, Right | 1999 |
Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension.
Topics: Acute Disease; Adenosine; Administration, Inhalation; Animals; Chronic Disease; Drug Therapy, Combination; Epoprostenol; Hypertension, Pulmonary; Injections, Intravenous; Male; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1999 |
Adenosine plasma concentration in pulmonary hypertension.
Topics: Adenosine; Aged; Chromatography, High Pressure Liquid; Female; Femoral Artery; Heart Rate; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen Inhalation Therapy; Pulmonary Artery; Vascular Resistance | 1999 |
Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension.
Topics: Adenosine; Fatal Outcome; Gestational Age; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Very Low Birth Weight; Infusions, Intravenous; Male; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Vasodilator Agents | 1999 |
Plasma beta-endorphin and adenosine concentration in pulmonary hypertension.
Topics: Adenosine; Adult; beta-Endorphin; Biomarkers; Blood Gas Analysis; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen Inhalation Therapy; Prognosis; Pulmonary Wedge Pressure; Radioimmunoassay | 2000 |
Severe pulmonary hypertension associated with COPD.
Topics: Adenosine; Aged; Blood Pressure; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Lung Transplantation; Male; Middle Aged; Vascular Resistance; Vasodilation; Vasodilator Agents | 2000 |
Adenosine is a pulmonary vasodilator in newborn lambs.
Topics: Adenosine; Analysis of Variance; Animals; Animals, Newborn; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Oxygen; Pulmonary Artery; Sheep; Sheep Diseases; Vasodilator Agents | 1992 |
Comparison of the effects of adenosine and nifedipine in pulmonary hypertension.
Topics: Adenosine; Adult; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Female; Humans; Hypertension, Pulmonary; Male; Nifedipine; Vascular Resistance; Vasodilation | 1992 |
Influence of adenosine and prostacyclin on hypoxia-induced pulmonary hypertension in the anaesthetized pig.
Topics: Adenosine; Animals; Epoprostenol; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Swine | 1991 |
Adenosine as a vasodilator in primary pulmonary hypertension.
Topics: Adenosine; Adult; Female; Humans; Hypertension, Pulmonary; Infusions, Intra-Arterial; Male; Pulmonary Circulation; Vascular Resistance; Vasodilator Agents | 1991 |
Adenosine and selective reduction of pulmonary vascular resistance in primary pulmonary hypertension.
Topics: Adenosine; Humans; Hypertension, Pulmonary; Pulmonary Circulation; Vascular Resistance; Vasodilator Agents | 1991 |
Vascular resistance and Kf in normal and PMA-injured rabbit lungs: effects of adenosine.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine Nucleotides; Adenosine; Animals; Capillary Permeability; Filtration; Hypertension, Pulmonary; In Vitro Techniques; Leukocyte Adherence Inhibition Test; Leukocyte Count; Lung Compliance; Lung Diseases; Male; Perfusion; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Rabbits; Tetradecanoylphorbol Acetate; Thromboxane B2; Vascular Resistance | 1991 |